Basic Information
Dose Medical is developing a variety of minimally invasive, bioerodible, sustained-release drug delivery platforms for the treatment of various retinal diseases, including age-related macular degeneration (AMD) and diabetic macular edema.
Dose Medical Corporation
LosAngeles,California,United States of America
unclear
April 19, 2010
--
--
Enterprise Profile
Industrial Sector
Concept
Application Scenarios